BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 6914866)

  • 1. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B
    Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activated C3 in the synovial fluid of patients with rheumatoid arthritis and arthrosis (correlations with C3, C4 and C3 proactivator/modification caused by storage)].
    Hasler F; Stojan B
    Z Rheumatol; 1981; 40(1):40-3. PubMed ID: 6908792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between inflammatory activity, immunoglobulins and complement components in the synovial fluid of patients with rheumatoid arthritis and arthrosis].
    Stojan B; Hasler F
    Schweiz Med Wochenschr; 1978 Jul; 108(30):1165-8. PubMed ID: 675210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
    Stojan B; Hasler F
    Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A benign form of rheumatoid arthritis, associated with low IgG, IgM and IgA and C3-proactivator concentrations in the serum].
    Stojan B; Hasler F
    Z Rheumatol; 1980; 39(5-6):182-9. PubMed ID: 6903082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum immunoglobulin patterns in rheumatoid arthritis].
    Dreher R
    Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
    Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
    J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
    Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A; Whaley K
    J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C3 cleavage product in synovial fluids detected by immunofixation.
    Partsch G; Bauer K; Bröll H; Petera P; Dunky A; Merétey K
    Z Rheumatol; 1991; 50(2):82-5. PubMed ID: 1872046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
    Male DK; Roitt IM
    Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B
    Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement and immunoglobulins in rheumatoid arthritis].
    Tanner E; Kühn RA; Kunath H; Stelzner A
    Allerg Immunol (Leipz); 1974-1975; 20-21(1):73-6. PubMed ID: 4282832
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
    Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
    Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.